FDA approves new hepatitis C drug, Harvoni, however, the non-insurance covered drug costs $95,000?

Per the New York Times quotation and printed statement of the currently U.S. F.D.A. approved, and drug maker, Gilead's cure for Hep C: "Harvoni, A Hepatitis C Drug From Gilead, Wins F.D.A. Approval. The first complete treatment for hepatitis C that requires taking only a once-a-day pill won approval Friday from the Food and Drug Administration. The drug, called Harvoni from Gilead Sciences, could shorten the duration of treatment and provide the first all-oral regimen for many patients. The new drug also appears to be a bit less expensive for some patients than Gilead's existing blockbuster hepatitis C drug, Sovaldi, which has become the poster child for those complaining that the cost of medicines is out of control. Sovaldi costs $1,000 a pill, or $84,000 for a typical 12-week course of treatment, but it must be used with other drugs. Harvoni is even more expensive at $1,125 a pill, or $94,500 for a 12-week course of treatment (Pollack,10/10)" . Please contact the Gilead Company at 333 Lakeside Drive
Foster City, CA 94404
Phone: (650) 574-3000
Fax: (650) 522-5853
1-800-GILEAD-5 (1-800-445-3235)
E-mail: public_affairs@gilead.com - See more at: http://www.gilead.com/contact#sthash.8UJbu23B.dpuf
There should be a financial relief for this drug, or a reduction in cost. How is it that we have our governments approval for a cure, but is untouchable for medical insurance and too costly for anyone in todays economy to pay for...let alone the sufferers of Hep C. Do you know that Hep C can and has been transmitted by a giving of a gift...blood donation? Please contact our U.S.F.D.A. at:
Toll Free
(855) 543-3784, or
(301) 796-3400
druginfo@fda.hhs.gov